2. Academic Validation
  3. Novel Heteroaromatic Carboxamides as Plasma Kallikrein Inhibitors for Treating Diabetic Complications, Ocular Diseases, and Edema-Associated Diseases

Novel Heteroaromatic Carboxamides as Plasma Kallikrein Inhibitors for Treating Diabetic Complications, Ocular Diseases, and Edema-Associated Diseases

  • ACS Med Chem Lett. 2021 Oct 21;12(11):1637-1638. doi: 10.1021/acsmedchemlett.1c00530.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States.
PMID: 34795850 DOI: 10.1021/acsmedchemlett.1c00530
Figures
Products